PlainRecalls
FDA Drug Moderate Class II Terminated

Heparin Sodium, 25,000 USP units per 250mL, (100 USP units per mL) in 5% Dextrose injection, 250 ml Excel Container, B. Braun Medical Inc. Bethlehem, PA 18018, USA; API from Spain NDC: 0264-9587-20,

Reported: May 24, 2023 Initiated: May 9, 2023 #D-0579-2023

Product Description

Heparin Sodium, 25,000 USP units per 250mL, (100 USP units per mL) in 5% Dextrose injection, 250 ml Excel Container, B. Braun Medical Inc. Bethlehem, PA 18018, USA; API from Spain NDC: 0264-9587-20,

Reason for Recall

Subpotent: Low anti-factor IIa Potency.

Details

Recalling Firm
B. Braun Medical Inc
Units Affected
1,380
Distribution
Nationwide in the USA
Location
Irvine, CA

Frequently Asked Questions

What product was recalled?
Heparin Sodium, 25,000 USP units per 250mL, (100 USP units per mL) in 5% Dextrose injection, 250 ml Excel Container, B. Braun Medical Inc. Bethlehem, PA 18018, USA; API from Spain NDC: 0264-9587-20,. Recalled by B. Braun Medical Inc. Units affected: 1,380.
Why was this product recalled?
Subpotent: Low anti-factor IIa Potency.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 24, 2023. Severity: Moderate. Recall number: D-0579-2023.